Annual Shareholders Equity
-$33.97 M
-$47.55 M-350.32%
31 December 2023
Summary:
Heron Therapeutics annual stockholders equity is currently -$33.97 million, with the most recent change of -$47.55 million (-350.32%) on 31 December 2023. During the last 3 years, it has fallen by -$270.46 million (-114.37%). HRTX annual shareholders equity is now -108.41% below its all-time high of $403.83 million, reached on 31 December 2019.HRTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$40.01 M
-$2.06 M-5.44%
30 September 2024
Summary:
Heron Therapeutics quarterly stockholders equity is currently -$40.01 million, with the most recent change of -$2.06 million (-5.44%) on 30 September 2024. Over the past year, it has dropped by -$12.22 million (-43.98%). HRTX quarterly shareholders equity is now -109.26% below its all-time high of $431.89 million, reached on 30 June 2018.HRTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -350.3% | -44.0% |
| 3 y3 years | -114.4% | -133.7% |
| 5 y5 years | -109.2% | -114.0% |
HRTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -114.4% | at low | -133.7% | at low |
| 5 y | 5 years | -108.4% | at low | -109.9% | at low |
| alltime | all time | -108.4% | at low | -109.3% | at low |
Heron Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$40.01 M(+5.4%) |
| June 2024 | - | -$37.94 M(+12.4%) |
| Mar 2024 | - | -$33.77 M(-0.6%) |
| Dec 2023 | -$33.97 M(-350.3%) | -$33.97 M(+22.3%) |
| Sept 2023 | - | -$27.79 M(-29.3%) |
| June 2023 | - | -$39.28 M(+243.7%) |
| Mar 2023 | - | -$11.43 M(-184.2%) |
| Dec 2022 | $13.57 M(-82.5%) | $13.57 M(-39.5%) |
| Sept 2022 | - | $22.45 M(-203.3%) |
| June 2022 | - | -$21.74 M(-190.7%) |
| Mar 2022 | - | $23.96 M(-69.1%) |
| Dec 2021 | $77.57 M(-67.2%) | $77.57 M(-34.7%) |
| Sept 2021 | - | $118.84 M(-25.8%) |
| June 2021 | - | $160.11 M(-18.4%) |
| Mar 2021 | - | $196.22 M(-17.0%) |
| Dec 2020 | $236.49 M(-41.4%) | $236.49 M(-14.7%) |
| Sept 2020 | - | $277.15 M(-14.5%) |
| June 2020 | - | $324.06 M(-11.3%) |
| Mar 2020 | - | $365.47 M(-9.5%) |
| Dec 2019 | $403.83 M(+9.1%) | $403.83 M(+41.5%) |
| Sept 2019 | - | $285.44 M(-6.5%) |
| June 2019 | - | $305.36 M(-8.0%) |
| Mar 2019 | - | $331.81 M(-10.4%) |
| Dec 2018 | $370.16 M(+182.3%) | $370.16 M(-9.0%) |
| Sept 2018 | - | $406.81 M(-5.8%) |
| June 2018 | - | $431.89 M(+368.4%) |
| Mar 2018 | - | $92.21 M(-29.7%) |
| Dec 2017 | $131.14 M(-717.1%) | $131.14 M(+227.4%) |
| Sept 2017 | - | $40.05 M(-42.0%) |
| June 2017 | - | $69.08 M(-32.4%) |
| Mar 2017 | - | $102.16 M(-580.7%) |
| Dec 2016 | -$21.25 M(-118.0%) | -$21.25 M(-218.9%) |
| Sept 2016 | - | $17.88 M(-69.1%) |
| June 2016 | - | $57.84 M(-37.6%) |
| Mar 2016 | - | $92.68 M(-21.5%) |
| Dec 2015 | $118.11 M(+87.3%) | $118.11 M(-16.6%) |
| Sept 2015 | - | $141.70 M(-11.4%) |
| June 2015 | - | $159.87 M(+233.0%) |
| Mar 2015 | - | $48.00 M(-23.9%) |
| Dec 2014 | $63.06 M(-8.5%) | $63.06 M(-22.2%) |
| Sept 2014 | - | $81.01 M(-17.2%) |
| June 2014 | - | $97.85 M(+76.6%) |
| Mar 2014 | - | $55.41 M(-19.6%) |
| Dec 2013 | $68.94 M(+33.1%) | $68.94 M(+230.3%) |
| Sept 2013 | - | $20.87 M(-26.8%) |
| June 2013 | - | $28.50 M(-31.1%) |
| Mar 2013 | - | $41.38 M(-20.1%) |
| Dec 2012 | $51.82 M(+229.0%) | $51.82 M(-9.9%) |
| Sept 2012 | - | $57.52 M(+417.5%) |
| June 2012 | - | $11.12 M(-4.5%) |
| Mar 2012 | - | $11.63 M(-26.1%) |
| Dec 2011 | $15.75 M(+1097.0%) | $15.75 M(-17.9%) |
| Sept 2011 | - | $19.19 M(+1.6%) |
| June 2011 | - | $18.89 M(>+9900.0%) |
| Mar 2011 | - | $136.00 K(-89.7%) |
| Dec 2010 | $1.32 M(-80.6%) | $1.32 M(-48.0%) |
| Sept 2010 | - | $2.53 M(-36.8%) |
| June 2010 | - | $4.01 M(-39.3%) |
| Mar 2010 | - | $6.59 M(-3.0%) |
| Dec 2009 | $6.80 M(-10.6%) | $6.80 M(+1310.0%) |
| Sept 2009 | - | $482.00 K(-65.0%) |
| June 2009 | - | $1.38 M(-71.7%) |
| Mar 2009 | - | $4.87 M(-35.9%) |
| Dec 2008 | $7.60 M(-74.2%) | $7.60 M(-32.7%) |
| Sept 2008 | - | $11.29 M(-34.3%) |
| June 2008 | - | $17.18 M(-25.1%) |
| Mar 2008 | - | $22.95 M(-22.1%) |
| Dec 2007 | $29.47 M(+144.4%) | $29.47 M(-20.5%) |
| Sept 2007 | - | $37.08 M(-12.1%) |
| June 2007 | - | $42.16 M(+577.0%) |
| Mar 2007 | - | $6.23 M(-48.4%) |
| Dec 2006 | $12.06 M | $12.06 M(-31.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $17.53 M(-17.3%) |
| June 2006 | - | $21.20 M(-17.3%) |
| Mar 2006 | - | $25.63 M(+313.2%) |
| Dec 2005 | $6.20 M(-56.2%) | $6.20 M(-28.9%) |
| Sept 2005 | - | $8.72 M(-16.4%) |
| June 2005 | - | $10.44 M(-19.3%) |
| Mar 2005 | - | $12.94 M(-8.6%) |
| Dec 2004 | $14.15 M(+25.7%) | $14.15 M(-13.3%) |
| Sept 2004 | - | $16.33 M(-10.4%) |
| June 2004 | - | $18.22 M(+108.3%) |
| Mar 2004 | - | $8.75 M(-22.3%) |
| Dec 2003 | $11.26 M(-27.1%) | $11.26 M(-10.4%) |
| Sept 2003 | - | $12.58 M(-7.6%) |
| June 2003 | - | $13.61 M(-12.3%) |
| Mar 2003 | - | $15.51 M(+0.3%) |
| Dec 2002 | $15.46 M(-19.4%) | $15.46 M(-1.2%) |
| Sept 2002 | - | $15.65 M(-6.2%) |
| June 2002 | - | $16.69 M(-7.8%) |
| Mar 2002 | - | $18.11 M(-5.6%) |
| Dec 2001 | $19.17 M(-9.4%) | $19.17 M(-7.8%) |
| Sept 2001 | - | $20.78 M(+8.5%) |
| June 2001 | - | $19.15 M(-5.7%) |
| Mar 2001 | - | $20.30 M(-4.1%) |
| Dec 2000 | $21.16 M(+75.8%) | $21.16 M(-6.4%) |
| Sept 2000 | - | $22.60 M(+89.2%) |
| June 2000 | - | $11.94 M(-4.0%) |
| Mar 2000 | - | $12.44 M(+3.4%) |
| Dec 1999 | $12.04 M(+33.7%) | $12.04 M(+14.6%) |
| Sept 1999 | - | $10.50 M(-32.7%) |
| June 1999 | - | $15.60 M(+3.3%) |
| Mar 1999 | - | $15.10 M(+67.8%) |
| Dec 1998 | $9.00 M(-11.8%) | $9.00 M(-31.8%) |
| Sept 1998 | - | $13.20 M(+4.8%) |
| June 1998 | - | $12.60 M(+5.0%) |
| Mar 1998 | - | $12.00 M(+17.6%) |
| Dec 1997 | $10.20 M(+104.0%) | $10.20 M(+20.0%) |
| Sept 1997 | - | $8.50 M(+21.4%) |
| June 1997 | - | $7.00 M(+22.8%) |
| Mar 1997 | - | $5.70 M(+14.0%) |
| Dec 1996 | $5.00 M(-3.8%) | $5.00 M(-34.2%) |
| Sept 1996 | - | $7.60 M(-19.1%) |
| June 1996 | - | $9.40 M(+8.0%) |
| Mar 1996 | - | $8.70 M(+67.3%) |
| Dec 1995 | $5.20 M(-55.9%) | $5.20 M(-44.7%) |
| Sept 1995 | - | $9.40 M(-13.8%) |
| June 1995 | - | $10.90 M(-12.8%) |
| Mar 1995 | - | $12.50 M(+5.9%) |
| Dec 1994 | $11.80 M(+12.4%) | $11.80 M(-8.5%) |
| Sept 1994 | - | $12.90 M(-9.2%) |
| June 1994 | - | $14.20 M(+32.7%) |
| Mar 1994 | - | $10.70 M(+1.9%) |
| Dec 1993 | $10.50 M(-48.0%) | $10.50 M(-21.6%) |
| Sept 1993 | - | $13.40 M(-15.7%) |
| June 1993 | - | $15.90 M(-14.1%) |
| Mar 1993 | - | $18.50 M(-8.4%) |
| Dec 1992 | $20.20 M(+551.6%) | $20.20 M(-6.9%) |
| Sept 1992 | - | $21.70 M(+17.9%) |
| June 1992 | - | $18.40 M(+20.3%) |
| Mar 1992 | - | $15.30 M(+393.5%) |
| Dec 1991 | $3.10 M(-50.8%) | $3.10 M(-18.4%) |
| Sept 1991 | - | $3.80 M(-19.1%) |
| June 1991 | - | $4.70 M(-9.6%) |
| Mar 1991 | - | $5.20 M(-17.5%) |
| Dec 1990 | $6.30 M(-33.7%) | $6.30 M(-8.7%) |
| Sept 1990 | - | $6.90 M(-14.8%) |
| June 1990 | - | $8.10 M(-5.8%) |
| Mar 1990 | - | $8.60 M(-9.5%) |
| Dec 1989 | $9.50 M(-28.6%) | $9.50 M(-11.2%) |
| Sept 1989 | - | $10.70 M(-7.8%) |
| June 1989 | - | $11.60 M(-12.8%) |
| Dec 1988 | $13.30 M(-22.7%) | $13.30 M(-22.7%) |
| Dec 1987 | $17.20 M | $17.20 M |
FAQ
- What is Heron Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Heron Therapeutics?
- What is Heron Therapeutics annual shareholders equity year-on-year change?
- What is Heron Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Heron Therapeutics?
- What is Heron Therapeutics quarterly shareholders equity year-on-year change?
What is Heron Therapeutics annual stockholders equity?
The current annual shareholders equity of HRTX is -$33.97 M
What is the all time high annual shareholders equity for Heron Therapeutics?
Heron Therapeutics all-time high annual stockholders equity is $403.83 M
What is Heron Therapeutics annual shareholders equity year-on-year change?
Over the past year, HRTX annual stockholders equity has changed by -$47.55 M (-350.32%)
What is Heron Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of HRTX is -$40.01 M
What is the all time high quarterly shareholders equity for Heron Therapeutics?
Heron Therapeutics all-time high quarterly stockholders equity is $431.89 M
What is Heron Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, HRTX quarterly stockholders equity has changed by -$12.22 M (-43.98%)